Equity Mates Investing Podcast cover image

Ren talks Resmed + GQG Partners, UFC and WWE are merging, & trying to perfect DCA investing

Equity Mates Investing Podcast

00:00

Investing in ResMed and Analyzing its Potential

The hosts discuss the impact of a drug called Zempic on ResMed and analyze the potential outcomes and valuation of the company based on different growth scenarios and price-to-earnings ratios. They also discuss the vulnerability of revenue drivers and share their investment strategy and decision-making process.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app